Verrica Pharmaceuticals I...

NASDAQ: VRCA · Real-Time Price · USD
6.15
-0.44 (-6.68%)
At close: Aug 14, 2025, 3:59 PM
6.03
-1.95%
After-hours: Aug 14, 2025, 05:12 PM EDT

Verrica Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
46.33M 69.55M 34.27M 15.75M
Short-Term Investments
n/a n/a n/a 54.6M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
376K 452K n/a n/a
Receivables
77K 4.42M 487K n/a
Inventory
2.46M 1.02M -487K n/a
Other Current Assets
2.31M n/a 487K n/a
Total Current Assets
51.18M 77.53M 39.12M 74.33M
Property-Plant & Equipment
2.58M 3.62M 5.61M 5.8M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.96M 4.07M 5.61M 5.8M
Total Assets
54.13M 81.6M 44.72M 80.13M
Account Payables
1.9M 2.46M 507K 845K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
12.94M 700K 297K 41.69M
Other Current Liabilities
12.34M 8.34M 1.1M 255K
Total Current Liabilities
29.01M 17.02M 3.46M 46.05M
Long-Term Debt
30.98M 42.87M n/a n/a
Other Long-Term Liabilities
2.65M n/a n/a n/a
Total Long-Term Liabilities
34.98M 44.81M 1.23M 1.47M
Total Liabilities
63.99M 61.83M 4.69M 47.52M
Total Debt
45.94M 45.51M 1.53M 43.41M
Common Stock
9K 4K 4K 3K
Retained Earnings
-307.03M -230.45M -163.45M -138.97M
Comprehensive Income
n/a n/a n/a -29K
Shareholders Equity
-9.86M 19.76M 40.03M 32.6M
Total Investments
n/a n/a n/a 54.6M